Is this the sort of thing you are referring to? https://www.technologyreview.com/2019/08/22/133291/the-next-trick-for-crispr-is-gene-editing-pain-away/
Other than that, Flexion therapeutics' FX301 is a drug to look out for, set to initiate Phase 1b soon (Flexion acquired the rights to develop Xenon's XEN402)
